Alto Ingredients, Inc. Common Stock vs. Codexis, Inc.
Alto Ingredients, Inc. Common Stock (ALTO) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ALTO | CDXS | |
|---|---|---|
| Market Cap | $307.17 million | $160.43 million |
| Revenue (TTM) | $943.33 million | $77.68 million |
| Net Income (TTM) | $51.99 million | $-30,723,000 |
ALTO leads on 3 of 3 size & scale factors.
Valuation
| ALTO | CDXS | |
|---|---|---|
| P/E Ratio | 5.79 | — |
| Price / Book | 1.18 | 4.87 |
| Price / Sales | 0.33 | 2.07 |
ALTO leads on 2 of 2 valuation factors.
Profitability
| ALTO | CDXS | |
|---|---|---|
| Net Margin | 5.51% | -39.55% |
| Return on Equity | 20.00% | -93.22% |
ALTO leads on 2 of 2 profitability factors.
Risk & Sentiment
| ALTO | CDXS | |
|---|---|---|
| Short Interest | 6.77% | 2.11% |
CDXS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALTO overview, ALTO financials, CDXS overview, CDXS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.